NCT06868524 Leading Healthy Eating and Activity Promotion Program
| NCT ID | NCT06868524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Cancer Survivor |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2029-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-10-30 with a primary completion date of 2029-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18 and 89 * English speaking * Resident of Birmingham area or surrounding community * History of any type of cancer or the friend or family with of a cancer survivor Exclusion Criteria: * Serious difficulty hearing * History of dementia or organic brain syndrome * On primary treatment for cancer * No other other medical, psychological, or social characteristic that would interfere with participation in evaluation
Contact & Investigator
Laura Rogers, MD
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06868524 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Cancer Survivor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06868524 currently recruiting?
Yes, NCT06868524 is actively recruiting participants. Contact the research team at sburdette@uabmc.edu for enrollment information.
Where is the NCT06868524 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06868524 clinical trial?
NCT06868524 is sponsored by University of Alabama at Birmingham. The principal investigator is Laura Rogers, MD at University of Alabama at Birmingham. The trial plans to enroll 100 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.